Senior Director, Drug Substance Manufacturing
Dyne Therapeutics
About this role
Senior Director, Drug Substance Manufacturing at Dyne Therapeutics leads the organization’s strategy for drug substance (Fab-oligonucleotide conjugates) development and CMC capabilities to support clinical programs and commercialization. The role partners cross-functionally with Development, R&D, Clinical, Regulatory Affairs, Project Management, and executive leadership and coordinates external manufacturing and testing partners. The position is based in Waltham, MA and supports building scalable clinical supply chain and regulatory readiness.
Skills
Qualifications
About Dyne Therapeutics
dyne-tx.comDyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for rare, inherited muscle diseases. With the mission "Repairing muscle, reclaiming now," it aims to create life‑transforming medicines that restore muscle function and improve patients' lives. Dyne advances programs from discovery into clinical development with a focus on genetic muscle disorders (including various muscular dystrophies) and works with partners to accelerate delivery of therapies to patients.
Recent company news
Seeking AlphaDyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)
2 days ago
Yahoo FinanceDyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
3 days ago
AlphaStreetDyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
22 hours ago
Stock Titan150-patient Dyne trial focuses on myotonic dystrophy daily function
3 days ago
Investor's Business DailyStocks Flashing Renewed Technical Strength: Dyne Therapeutics
1 day ago
About Dyne Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Dyne Therapeutics.
Salary
$217k – $267k
per year
More jobs at Dyne Therapeutics
Similar Jobs
Senior Director, CMC Drug Substance Development & Manufacturing
Olema Oncology
Quality R&D Operations Drug Substance Director
GSK plc
Senior Director, CMC Drug Substance Development & Manufacturing
Olema Oncology
Associate Director, Drug Substance
Sanofi
Intern, CMC Drug Substance
Eikon Therapeutics
Associate Director, Drug Substance Manufacturing
Akero Therapeutics